Skip to content

Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis

Observational Study to Procure Human Specimens for Use in the Diagnosis and Management of Sepsis and Other Related Conditions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01746407
Acronym
EMOS
Enrollment
872
Registered
2012-12-11
Start date
2012-12-31
Completion date
2014-12-31
Last updated
2015-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Keywords

Emergency Department, Infection, Sepsis

Brief summary

Procure blood specimens from individuals presenting to the emergency department (ED) with signs and /or symptoms of systemic infection or sepsis. The samples will be used for research and development activities related to sepsis, infections, etc.

Interventions

None listed

Sponsors

Abbott Diagnostics Division
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 yrs of age or older * For women of child bearing years: not known to be pregnant * Blood culture ordered as part of the ED, ICU (or equivalent) or hospital floor stay.

Exclusion criteria

* Previously enrolled in this study * Vulnerable individual * Unable to speak and/or understand English

Design outcomes

Primary

MeasureTime frameDescription
Progression of infection to severe sepsis72 hoursAssessment of the progression of infection to severe sepsis in an ED population who present with signs or symptoms of infection.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026